565
Recombinant Human IgE Antibodies to Analyze Antigenic Determinants in Group 1 Mite Allergens for the Design of Immunotherapy
Sunday, March 6, 2016
South Exhibit Hall H (Convention Center)
Anna Pomés, PhD FAAAAI, Jill Glesner, BS, Magdalena Godzwon, MSc, Mattias Levin, PhD, Martin D. Chapman, PhD FAAAAI, Mats Ohlin, PhD
Rationale: Little is known about the molecular features of IgE antibody binding epitopes and their distribution on allergenic molecules.  The goal is to analyze IgE antigenic determinants of group 1 dust mite allergens in order to, through a knowledge-based approach, design modified allergens with reduced IgE reactivity and retained immunogenicity, as candidates for immunotherapy, given their potential to decrease side-effects due to IgE cross-linking. 

Methods: Der p 1-specific single-chain variable fragments (scFv) were isolated from combinatorial libraries constructed from the IgE repertoire of mite allergic patients and displayed on filamentous phage. They were produced fused to immunoglobulin Fc domains and analyzed for allergen binding by direct and inhibition immunoassays.  A scFv was expressed in yeast Pichia pastoris and purified by affinity chromatography.    

Results: Two isolated scFv bound strongly to natural Der p 1 by ELISA with different epitope specificity, by comparing with Der p 1-specific mAb of known specificity.  A soluble Der p 1-specific scFv did not bind the homolog Der f 1, despite interfering with the binding of mAb-4C1, which recognizes a cross-reacting epitope in both allergens.  The overlap of both epitopes was proven by: a) its lack of recognition of the allergen captured by mAb-4C1 and b) the inhibition of the scFv binding to nDer p 1 by mAb-4C1.  The scFv was expressed in yeast Pichia pastoris in mg amounts suitable for crystallographic analysis.

Conclusions: Recombinant IgE from combinatorial libraries provide tools for analysis of antigenic determinants in the context of the human IgE antibody repertoire and for the design of immunotherapy.